Literature DB >> 19224196

Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

E Ferrannini1, M Massari, M Nannipieri, A Natali, R Lopez Ridaura, C Gonzales-Villalpando.   

Abstract

AIMS/HYPOTHESIS: The value of diagnostic categories of glucose intolerance for predicting type 2 diabetes is much debated. We therefore sought to estimate relative and population-attributable risk of different definitions based on fasting (impaired fasting glucose [IFG]) or 2 h plasma glucose concentrations (impaired glucose tolerance [IGT]) and to describe the associated clinical phenotypes.
METHODS: We prospectively observed a population-based cohort of 1,963 non-diabetic participants (mean age 47 years), in whom an OGTT was performed at baseline and 7 years later.
RESULTS: IGT was fivefold more prevalent (13.5%) than IFG. In both categories, participants were older, heavier, hyperinsulinaemic, hyperproinsulinaemic and dyslipidaemic compared with participants with normal glucose tolerance. Relative risk of incident diabetes was similar for IFG and IGT categories (3.73 [95% CI: 2.18-6.39] and 4.01 [95% CI: 3.12-5.14], respectively), but the population-attributable risk was fivefold higher for IGT (29% [95% CI: 26-32]) than for IFG (6% [95% CI: 5-7]). Isolated IFG carried no increase in risk. Lowering the threshold to 5.6 mmol/l raised the population-attributable risk of IFG to 23% (95% CI: 20-25); its contribution to diabetes progression, however, was largely due to co-existent IGT. In multivariate analysis adjusting for sex, age, familial diabetes and BMI, fasting and 2 h glucose were independent predictors. CONCLUSIONS/
INTERPRETATION: Fasting and 2 h glucose values are independent predictors of incident diabetes. Isolated IFG is not a high-risk condition; lowering the diagnostic threshold increases the population-attributable risk of IFG fourfold, but performing an OGTT captures additional diabetes progressors compared with the number identified by IFG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224196     DOI: 10.1007/s00125-009-1289-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

Review 2.  Follow-up report on the diagnosis of diabetes mellitus.

Authors:  Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

3.  Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.

Authors:  James S Pankow; David K Kwan; Bruce B Duncan; Maria I Schmidt; David J Couper; Sherita Golden; Christie M Ballantyne
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

4.  Back to the future--do IGT and IFG have value as clinical entities?

Authors:  Stephen Colagiuri; Knut Borch-Johnsen; Nicholas J Wareham
Journal:  Diabetes Res Clin Pract       Date:  2008-08       Impact factor: 5.602

5.  Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

Authors:  F de Vegt; J M Dekker; A Jager; E Hienkens; P J Kostense; C D Stehouwer; G Nijpels; L M Bouter; R J Heine
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

6.  Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

Authors:  Monica Nannipieri; Clicerio Gonzales; Simona Baldi; Rosalinda Posadas; Ken Williams; Steven M Haffner; Michael P Stern; Ele Ferrannini
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

7.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

8.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

9.  Individuals with high total cholesterol/HDL cholesterol ratios are insulin resistant.

Authors:  J Jeppesen; F S Facchini; G M Reaven
Journal:  J Intern Med       Date:  1998-04       Impact factor: 8.989

10.  The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group.

Authors:  N G Forouhi; B Balkau; K Borch-Johnsen; J Dekker; C Glumer; Q Qiao; A Spijkerman; R Stolk; A Tabac; N J Wareham
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

View more
  13 in total

Review 1.  Impaired fasting glucose as a treatment target in diabetes management.

Authors:  Rene A Oliveros; Adrienne S Zion; Yelena Rosenberg; Carrie Lynn Selvaraj; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

2.  A novel test for IGT utilizing metabolite markers of glucose tolerance.

Authors:  Jeff Cobb; Andrea Eckhart; Regis Perichon; Jacob Wulff; Matthew Mitchell; Klaus-Peter Adam; Robert Wolfert; Eric Button; Kay Lawton; Robert Elverson; Bernadette Carr; Margaret Sinnott; Ele Ferrannini
Journal:  J Diabetes Sci Technol       Date:  2014-09-26

3.  Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study.

Authors:  E Ferrannini; A Natali; E Muscelli; P M Nilsson; A Golay; M Laakso; H Beck-Nielsen; A Mari
Journal:  Diabetologia       Date:  2011-03-22       Impact factor: 10.122

4.  Effects of cardiorespiratory fitness on aging: glucose trajectory in a cohort of healthy men.

Authors:  Xuemei Sui; Andrew S Jackson; Timothy S Church; Duck-Chul Lee; Daniel P O'Connor; Jihong Liu; Steven N Blair
Journal:  Ann Epidemiol       Date:  2012-07-03       Impact factor: 3.797

5.  Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance.

Authors:  Dianna J Magliano; Stefan Söderberg; Paul Z Zimmet; Bendix Cartensen; Beverly Balkau; Vassen Pauvaday; Sudhir Kowlessur; Jaakko Tuomilehto; K George M M Alberti; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

6.  Detecting prediabetes among Hispanics/Latinos from diverse heritage groups: Does the test matter? Findings from the Hispanic Community Health Study/Study of Latinos.

Authors:  M Larissa Avilés-Santa; Cynthia M Pérez; Neil Schneiderman; Peter J Savage; Robert C Kaplan; Yanping Teng; Erick L Suárez; Jianwen Cai; Aida L Giachello; Gregory A Talavera; Catherine C Cowie
Journal:  Prev Med       Date:  2016-12-10       Impact factor: 4.018

Review 7.  Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

Authors:  Michael Bergman
Journal:  Endocrine       Date:  2012-11-07       Impact factor: 3.633

Review 8.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

9.  Increases in waist circumference and weight as predictors of type 2 diabetes in individuals with impaired fasting glucose: influence of baseline BMI: data from the DESIR study.

Authors:  Alain Gautier; Ronan Roussel; Pierre H Ducluzeau; Céline Lange; Sylviane Vol; Beverley Balkau; Fabrice Bonnet
Journal:  Diabetes Care       Date:  2010-05-18       Impact factor: 19.112

10.  High prevalence of hyperglycaemia and the impact of high household income in transforming rural China.

Authors:  Chaowei Fu; Yue Chen; Fadi Wang; Xuecai Wang; Jiangen Song; Qingwu Jiang
Journal:  BMC Public Health       Date:  2011-11-12       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.